BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 27 filers reported holding BIOLINERX LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $14,000 | -46.2% | 33,531 | -42.6% | 0.00% | – |
| Q4 2018 | $26,000 | +136.4% | 58,376 | +346.3% | 0.00% | – |
| Q1 2018 | $11,000 | -54.2% | 13,081 | -40.1% | 0.00% | – |
| Q4 2017 | $24,000 | +84.6% | 21,820 | +91.9% | 0.00% | – |
| Q3 2017 | $13,000 | -87.3% | 11,371 | -89.3% | 0.00% | – |
| Q1 2017 | $102,000 | +466.7% | 105,986 | +443.4% | 0.00% | – |
| Q4 2016 | $18,000 | -5.3% | 19,505 | +18.6% | 0.00% | – |
| Q3 2016 | $19,000 | -73.6% | 16,448 | -49.2% | 0.00% | – |
| Q1 2014 | $72,000 | – | 32,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,501,000 | $2,432,000 | 0.47% |
| Senvest Management, LLC | 2,278,995 | $3,692,000 | 0.26% |
| Opaleye Management Inc. | 250,000 | $405,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 928,758 | $1,505,000 | 0.05% |
| Benchmark Capital Advisors | 40,000 | $65,000 | 0.04% |
| Orbimed Advisors | 1,135,000 | $1,839,000 | 0.02% |
| NEXT Financial Group, Inc | 28,500 | $46,000 | 0.02% |
| Cutter & CO Brokerage, Inc. | 10,000 | $16,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 110 | $0 | 0.00% |
| Renaissance Technologies | 26,878 | $44,000 | 0.00% |